Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care

31 January 2019

Wound Care: new clinical data show Nexodyn® AOS To reduce reinfections and healing time in diabetic foot ulcers

31 January 2019

Ebola: Promising Early-Stage Safety Clinical Trial Results For Potential Treatment Based On Antibodies Isolated In Switzerland

25 January 2019

Gabriel Haering at the Career Chat c/o ETH Zurich

17 January 2019

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

21 December 2018

RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®

20 December 2018

Advitech’s new project: APIsTRENDS – a collection of reports

18 December 2018

Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US

12 December 2018

Wound care: Nexodyn® AOS comes to fruition in Slovakia

12 December 2018

Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)

3 December 2018